A semi-automatic case packer from Omega Design and Brazil's Grupo Tecnor offers unit-level serialization capabilities.
Omega Design and Brazil-based packaging-equipment provider Grupo Tecnor introduced a jointly-developed semi-automatic case packer with unit-level serialization capabilities to the North American market. The ECX-001 Case Packer uses software, cameras, and printers integrated by Omega Design to meet the more stringent track-and-trace requirements mandated by the US Drug Quality and Security Act.
The case packer's semiautomatic functionality increases production and eliminates hand-packing costs while avoiding the expensive, often time-consuming transition to fully automatic operations. The machine has a heavy-duty welded tubular construction and uses Allen-Bradley components. The serialization and packing cycle offers maximum safety precautions, such as instant emergency-stop functions, which are important in semiautomatic operating scenarios. Completed cases are automatically discharged onto a free roller table.
To operate the packer, personnel open an empty case and place it in the loading funnel, where it is held in place to receive individual units. Once the collated units are packed into the case, an integrated camera captures the codes of each individual item and associates them to their case-label code in the serialization software. As this occurs, the operator can monitor the process on a nearby panel view.
Source: Omega Design
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.